Biomerica Inc
NASDAQ:BMRA

Watchlist Manager
Biomerica Inc Logo
Biomerica Inc
NASDAQ:BMRA
Watchlist
Price: 2.38 USD -1.86% Market Closed
Market Cap: $7m

Operating Margin

-100%
Current
Improving
by 8.6%
vs 3-y average of -108.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-100%
=
Operating Income
$-4.9m
/
Revenue
$4.9m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-100%
=
Operating Income
$-4.9m
/
Revenue
$4.9m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Biomerica Inc
NASDAQ:BMRA
6.8m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.2B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.4B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.2B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.1B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.9B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.1B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.7B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.4B USD
Loading...

Market Distribution

Lower than 85% of companies in the United States of America
Percentile
15th
Based on 14 112 companies
15th percentile
-100%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Biomerica Inc
Glance View

Market Cap
7m USD
Industry
Health Care

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company is headquartered in Irvine, California and currently employs 49 full-time employees. The firm develops, patents, manufactures and markets diagnostic and therapeutic products for the early detection and monitoring of chronic diseases and other medical conditions. The firm's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications, by measuring or detecting the of specific bacteria, hormones, antibodies, antigens, or other substances, in a patient body, stools, or blood, saliva or nasal fluid. The firm is engaged in research and development of disruptive, patented diagnostic guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases.

BMRA Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-100%
=
Operating Income
$-4.9m
/
Revenue
$4.9m
What is Biomerica Inc's current Operating Margin?

The current Operating Margin for Biomerica Inc is -100%, which is above its 3-year median of -108.6%.

How has Operating Margin changed over time?

Over the last 3 years, Biomerica Inc’s Operating Margin has decreased from -26.3% to -100%. During this period, it reached a low of -135.2% on May 31, 2023 and a high of -26.3% on Aug 31, 2022.

Back to Top